Key facts
- This page summarizes Ryan Charles Drexler's Form 4 filing for MusclePharm Corp.
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 17 Aug 2021, 21:56.
Ryan Charles Drexler - 13 Aug 2020 Form 4 Insider Report for MusclePharm Corp
- Reporting relationship
- CEO, Director, 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 13 Aug 2020
- Net transaction value
- +$2,457,549
- Reporting owner signature
- /s/ Ryan Charles Drexler
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Ryan Charles Drexler filed Form 4 for MusclePharm Corp on 17 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$2,457,549.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MSLP
transaction
Derivative
Convertible Promissory Note
Other
- Transaction value
- $2,457,549
- Shares
- Change %
- Price
- Shares after
- $2,457,549
- Date
- 13 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- Exercise price
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
On October 15, 2020, Mr. Drexler entered into a convertible secured promissory note agreement with a principal amount of $2,457,549 with the Company. (the "October 2020 Convertible Note"). Both the principal and any accrued but unpaid interest under the October 2020 Convertible Note will become due and payable on July 14, 2022, unless earlier converted or repaid.
Footnote F2
Closing price on October 15, 2021
Footnote F3
Determined on October 15, 2021